JP Morgan Chase
EDSA icon

JP Morgan Chase’s Edesa Biotech EDSA Stock Holding History

JP Morgan Chase’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67K Buy
+1,130
New +$10.2K ﹤0.01% 6959
2020
Q1 		– Sell
-14
Closed – – 5388
2019
Q4 		$0 Buy
+14
New +$495 ﹤0.01% 5662

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

JP Morgan Chase's EDSA Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Edesa Biotech (EDSA) in Q2 2026: 1,130 shares worth $8.67K. The stake represents ﹤0.01% of the portfolio and ranks #6959 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in EDSA as recently as Q4 2019.

JP Morgan Chase first reported a position in EDSA in Q4 2019 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • JP Morgan Chase held 1,130 shares of Edesa Biotech worth $8.67K as of Q2 2026.
  • Edesa Biotech was a new JP Morgan Chase position in Q2 2026.
  • Edesa Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6959 holding.
  • JP Morgan Chase first reported a position in Edesa Biotech in Q4 2019 and has held it in 2 quarters since.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.